Lemaitre Vascular (LMAT) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $81.54 -1.02%
Financial Fact:
Research and development: 1.54M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 1.54M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.27, $0.01 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $39.6 million versus the consensus estimate of $38.65 million.
GUIDANCE:
Lemaitre Vascular sees FY2022 EPS of $1.21-$1.31, versus the consensus of $1.40. Lemaitre Vascular sees FY2022 revenue of $160-164 million, versus the consensus of $165 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
